Abstract Details

Title IRX4204: A Highly Selective RXR Agonist Modulates Adaptive Treg Differentiation Independent of RAR, and Effectively Inhibits Central Nervous System Inflammation

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 005

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Elizabeth Nowak PRESENTER	No disclosure on file
Christopher Goetz, MD, FAAN (Rush University Medical Center)	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
	No disclosure on file
	No disclosure on file